End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-12 pm EDT
|
5-day change
|
1st Jan Change
|
23.17
CNY
|
-0.09%
|
|
-2.20%
|
-4.26%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,717
|
17,643
|
22,893
|
19,924
|
22,872
|
21,740
|
-
|
-
|
Enterprise Value (EV)
1 |
9,717
|
16,627
|
22,893
|
19,207
|
22,668
|
21,534
|
21,333
|
21,740
|
P/E ratio
|
248
x
|
-111
x
|
106
x
|
51.9
x
|
101
x
|
50.9
x
|
36.4
x
|
27.2
x
|
Yield
|
0.2%
|
0.16%
|
0.08%
|
0.23%
|
-
|
0.47%
|
0.64%
|
0.99%
|
Capitalization / Revenue
|
8.46
x
|
9.71
x
|
9.72
x
|
7.32
x
|
8.58
x
|
6.72
x
|
5.66
x
|
4.82
x
|
EV / Revenue
|
8.46
x
|
9.15
x
|
9.72
x
|
7.06
x
|
8.5
x
|
6.65
x
|
5.55
x
|
4.82
x
|
EV / EBITDA
|
-
|
-153
x
|
56.9
x
|
29.6
x
|
45.6
x
|
27.3
x
|
21.5
x
|
16.5
x
|
EV / FCF
|
-
|
91.5
x
|
-
|
-175
x
|
-51.3
x
|
743
x
|
121
x
|
68.8
x
|
FCF Yield
|
-
|
1.09%
|
-
|
-0.57%
|
-1.95%
|
0.13%
|
0.83%
|
1.45%
|
Price to Book
|
2.57
x
|
4.97
x
|
5.68
x
|
4.79
x
|
5.12
x
|
4.54
x
|
4.1
x
|
3.59
x
|
Nbr of stocks (in thousands)
|
981,468
|
933,022
|
940,539
|
935,824
|
945,118
|
938,283
|
-
|
-
|
Reference price
2 |
9.900
|
18.91
|
24.34
|
21.29
|
24.20
|
23.17
|
23.17
|
23.17
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,149
|
1,817
|
2,356
|
2,721
|
2,667
|
3,236
|
3,843
|
4,512
|
EBITDA
1 |
-
|
-108.6
|
402.5
|
649.8
|
496.8
|
788.5
|
991.4
|
1,321
|
EBIT
1 |
19.35
|
-215.9
|
289.5
|
488.6
|
319
|
579.6
|
791.2
|
1,079
|
Operating Margin
|
1.68%
|
-11.88%
|
12.29%
|
17.95%
|
11.96%
|
17.91%
|
20.59%
|
23.91%
|
Earnings before Tax (EBT)
1 |
30.77
|
-91.87
|
293.4
|
481.8
|
318.5
|
587.1
|
798
|
1,078
|
Net income
1 |
34.09
|
-159.8
|
213.5
|
390
|
222
|
428.2
|
601.3
|
807.1
|
Net margin
|
2.97%
|
-8.8%
|
9.06%
|
14.33%
|
8.32%
|
13.23%
|
15.65%
|
17.89%
|
EPS
2 |
0.0400
|
-0.1700
|
0.2300
|
0.4100
|
0.2400
|
0.4548
|
0.6372
|
0.8529
|
Free Cash Flow
1 |
-
|
181.7
|
-
|
-109.7
|
-442.2
|
29
|
176
|
316
|
FCF margin
|
-
|
10%
|
-
|
-4.03%
|
-16.58%
|
0.9%
|
4.58%
|
7%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
3.68%
|
17.75%
|
23.93%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
6.77%
|
29.27%
|
39.15%
|
Dividend per Share
2 |
0.0200
|
0.0300
|
0.0200
|
0.0500
|
-
|
0.1100
|
0.1475
|
0.2300
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q2
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
61.14
|
Net margin
|
-
|
EPS
2 |
0.0634
|
Dividend per Share
|
-
|
Announcement Date
|
8/18/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,016
|
-
|
716
|
204
|
206
|
407
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
182
|
-
|
-110
|
-442
|
29
|
176
|
316
|
ROE (net income / shareholders' equity)
|
0.91%
|
-4.39%
|
5.64%
|
8.97%
|
4.94%
|
9.06%
|
11.6%
|
13.2%
|
ROA (Net income/ Total Assets)
|
0.84%
|
-3.7%
|
4.47%
|
7.27%
|
-
|
6.07%
|
7.19%
|
8.62%
|
Assets
1 |
4,083
|
4,325
|
4,779
|
5,364
|
-
|
7,055
|
8,363
|
9,367
|
Book Value Per Share
2 |
3.860
|
3.800
|
4.280
|
4.450
|
4.730
|
5.110
|
5.660
|
6.450
|
Cash Flow per Share
2 |
0.2000
|
0.4200
|
0
|
0.5900
|
0.5700
|
0.6500
|
0.9500
|
1.050
|
Capex
1 |
206
|
207
|
372
|
673
|
977
|
417
|
447
|
509
|
Capex / Sales
|
17.93%
|
11.38%
|
15.77%
|
24.71%
|
36.61%
|
12.89%
|
11.63%
|
11.28%
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Last Close Price
23.17
CNY Average target price
25
CNY Spread / Average Target +7.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.26% | 3.01B | | +17.67% | 66.69B | | +1.79% | 49.2B | | +17.80% | 41.24B | | +20.17% | 25.89B | | +12.56% | 19.81B | | +2.80% | 17.11B | | -23.12% | 15.86B | | +2.62% | 15.35B | | -7.62% | 15.23B |
Other Specialty Chemicals
|